Delcath Systems Stock Quote DCTH - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Delcath Systems Inc (DCTH) Quote

Delcath Systems Inc (DCTH)

8.30

0.07

( 0.85% )

Updated: 14:40:36

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

8.30

Bid

8.30

Ask

8.39

Volume

137,843

8.08 Day's Range 8.428

2.25 52 Week Range 8.60

Market Cap

Previous Close

8.23

Open

8.29

Last Trade

Last Trade Time

14:43:34

Financial Volume

$ 1,138,754

VWAP

8.2612

Average Volume (3m)

266,868

Shares Outstanding

27,785,803

Dividend Yield

-

PE Ratio

-4.83

Earnings Per Share (EPS)

-1.72

Revenue

2.07M

Net Profit

-47.68M

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.delcath.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Delcath Systems Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DCTH. The last closing price for Delcath Systems was $8.23. Over the last year, Delcath Systems shares have traded in a share price range of $ 2.25 to $ 8.60.

Delcath Systems currently has 27,785,803 shares outstanding. The market capitalization of Delcath Systems is $228.68 million. Delcath Systems has a price to earnings ratio (PE ratio) of -4.83.

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors

Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.14	1.71568627451	8.16	8.428	7.37	230980	7.91909745	CS
4	0.2	2.46913580247	8.1	8.6	7.37	195905	8.03119554	CS
12	2.97	55.722326454	5.33	8.6	5.12	266868	7.239223	CS
26	4.38	111.734693878	3.92	8.6	3.7	235455	5.96223552	CS
52	3.28	65.3386454183	5.02	8.6	2.25	788879	5.24167828	CS
156	-1.49	-15.2196118488	9.79	14.95	2.25	289863	5.35839168	CS
260	4.53	120.159151194	3.77	25.18	2.25	238700	6.51871226	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 3.47 (403.77%)	133.3M
CMAXCareMax Inc	$ 5.2026 (229.28%)	89.17M
NUKKNukkleus Inc	$ 0.4576 (43.00%)	21.08M
LPSNLivePerson Inc	$ 1.315 (32.83%)	7.04M
SNOASonoma Pharmaceuticals Inc	$ 0.4007 (30.10%)	3.25M
CGBSCrown LNG Holdings Ltd	$ 0.99 (-29.79%)	2.89M
LGCBLinkage Global Inc	$ 3.6833 (-29.37%)	158.61k
SLNASelina Hospitality PLC	$ 0.0357 (-24.52%)	63.21M
PSIGPS International Group Ltd	$ 2.62 (-23.17%)	317.33k
SPECSpectaire Holdings Inc	$ 0.405 (-22.86%)	1.63M
NVDANVIDIA Corporation	$ 123.63 (4.83%)	182.94M
SQQQProShares UltraPro Short QQQ	$ 8.0569 (-4.76%)	152.06M
MIRAMIRA Pharmaceuticals Inc	$ 3.47 (403.77%)	133.3M
SERVServe Robotics Inc	$ 9.295 (23.11%)	130.98M
NCPLNetcapital Inc	$ 0.1117 (7.40%)	117.29M

Filterthenoise

Filterthenoise 1 month ago

Straight 🔥 $DCTH

Monksdream

Monksdream 1 month ago

Filterthenoise

Filterthenoise 2 months ago

Monksdream

Monksdream 4 months ago

DCTH 10Q due 3/26

Filterthenoise

Filterthenoise 6 months ago

Filterthenoise

Filterthenoise 8 months ago

green maschine

green maschine 11 months ago

6 now. That was quick.

TheFinalCD

TheFinalCD 11 months ago

green maschine

green maschine 11 months ago

The 5 analysts offering 12-month price forecasts for Delcath Systems Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a +216.62% increase from the last price of 5.69.

dande1990

dande1990 11 months ago

H.C. Wainwright Reaffirms Their Buy Rating on Delcath Systems (DCTH)

TipRanks

Aug. 15, 2023, 09:35 AM

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Delcath Systems (DCTH – Research Report), with a price target of $18.00. The company’s shares opened today at $5.84.

dande1990

dande1990 11 months ago

HC Wainwright & Co. Maintains Delcath Systems (DCTH) Buy Recommendation

Story by George Maybach • 14h

?

Fintel reports that on August 15, 2023, HC Wainwright & Co. maintained coverage of Delcath Systems (NASDAQ:DCTH) with a Buy recommendation.
Analyst Price Forecast Suggests 436.15% Upside
As of August 2, 2023, the average one-year price target for Delcath Systems is 16.73. The forecasts range from a low of 10.10 to a high of $23.10. The average price target represents an increase of 436.15% from its latest reported closing price of 3.12.

TheFinalCD

TheFinalCD 11 months ago

5.13 LO :/

SO FAR

green maschine

green maschine 11 months ago

Hope you get that back working soon. I use TD Ameritrade and so far haven't had any problems with their system.

dande1990

dande1990 11 months ago

No... On my app and my laptop I have a message saying they are unable to at the moment

$DCTH

green maschine

green maschine 11 months ago

Wow, bummer. Did they say why?

dande1990

dande1990 11 months ago

Fidelity is down. Cant make trades at all.

$DCTH

green maschine

green maschine 11 months ago

Awesome! I need to get my correct my sleeping habits - kicking myself today.

dande1990

dande1990 11 months ago

Ive been able to do 5.01 to 5.77 and 5.55 to 7.25. In again at 6.33.

green maschine

green maschine 11 months ago

Nice move CD. Still climbing. $$DCTH$$

green maschine

green maschine 11 months ago

I'm in at 5.43, went back to bed and missed the flip today. Oh well might see 10 by EOW.

dande1990

dande1990 11 months ago

This board needs some life!! Lets go $DCTH

TheFinalCD

TheFinalCD 11 months ago

round ii

filled as low as 6.46 on that DIP

$DCTH

TheFinalCD

TheFinalCD 11 months ago

$7!!!!!!!!!!!!!!

SOLD SOME 6.95 AFTER 7 COULDNT BREAK HARD

TheFinalCD

TheFinalCD 11 months ago

SriMaharaj

SriMaharaj 11 months ago

Told you guys. Get in now before it's too late.

SriMaharaj

SriMaharaj 11 months ago

Wait until it cross $6. You will see $10 today or tomorrow.

TheFinalCD

TheFinalCD 11 months ago

6.50 WAS A NICE POP OFF MY 5.55 ENTRY

green maschine

green maschine 11 months ago

Yeah there's resistance at that level, but I believe it'll break through today. Too much buying pressure here. FDA approval is huge news.

Filterthenoise

Filterthenoise 11 months ago

TheFinalCD

TheFinalCD 11 months ago

6.24 SO FAR BUT THEY QUICKLY SOLD IT OFF TO 5.34

DCTH

Monksdream

Monksdream 11 months ago

Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

green maschine

green maschine 11 months ago

Good morning. I wonder how high this flies today.

TheFinalCD

TheFinalCD 11 months ago

https://finviz.com/quote.ashx?t=DCTH&p=d

$DCTH 🚨 Approved

Finally after years of try.

Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma. pic.twitter.com/ZCBQZXbgzE— Ripster📈📉 (@ripster47) August 15, 2023

green maschine

green maschine 11 months ago

Where is everybody?

Carlito78

Carlito78 11 months ago

What ever happened to SamnotSamuel?

harvest1

harvest1 12 months ago

Wow stock is down 2 weeks before PDUFA date. Hard to imagine this wont be approved this time with no adcom. Not sure why there arent more buyers. Hopefully there is a pop on approval and they have a quick launch and revenue ramp.

Filterthenoise

Filterthenoise 1 year ago

Finally! Go $DCTH

Jmma

Jmma 1 year ago

Finally looks promising for real. Had shares few years ago and got chewed up and spit out . Reverse splits wiped out a lot of investors. Looks like they turned the corner and could become the investment everyone hoped for awhile back. Good luck to those holding.

Filterthenoise

Filterthenoise 1 year ago

No one loving the start of the run?

Filterthenoise

Filterthenoise 2 years ago

Next leg time LFG $DCTH!!

Filterthenoise

Filterthenoise 2 years ago

Filterthenoise

Filterthenoise 2 years ago

Let's GO!

$DCTH

Filterthenoise

Filterthenoise 2 years ago

Another run at it coming

GLTA

harvest1

harvest1 2 years ago

A new corporate presentation was posted to the company's website with alot of updated information.
https://delcath.com/investors/events-presentations/

This company has been left for dead by the market but I think the stock could recover strongly next year after approval if revenues begin to roll in. I would be interested to hear others thoughts on catalysts and stock price targets. I think at least a $100 million market cap should be expected on approval. Longer term at least $250 million market cap when revenues are material. Starting 3 new trials in 2023 will be positive as well. There appears to be little interest or attention for the company now but hopefully that changes after approval. My biggest fear is that they will have to dilute more at these awful rock bottom prices.

Filterthenoise

Filterthenoise 2 years ago

nealhugh

nealhugh 2 years ago

just waiting.........................................................................

nealhugh

nealhugh 2 years ago

yup--- good chat with GA... TY. Neal

nealhugh

nealhugh 2 years ago

FDA submission Summer/Fall 2022
FDA approval possible within 6 mos of submission

Fund raise? when?

Stock price lousy so wait for the fund raise?

All results on trials and use are good!

TY, Neal

nealhugh

nealhugh 2 years ago

https://ih.advfn.com/p.php?pid=nmona&article=87441339

nealhugh

nealhugh 2 years ago

Yeah--- I had Covid so I have been delayed!!! :)

Delcath Systems

Gilead Sciences

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions